MR. GEORGE VASILIOS LETSOU, MD

Plain English
This study looked at a new method for measuring the volume of the left ventricle in the heart, which is important for understanding heart function, especially in patients with heart failure. The researchers developed a simple formula to estimate this volume using just one heartbeat's data, showing that their method works well in tests with 10,000 different heart shapes. By using this new approach, doctors can more accurately assess heart function without needing to change the patient's condition, which is especially useful when traditional methods aren’t safe. Who this helps: This benefits patients with heart failure and their doctors by providing better assessments of heart function.

Plain English
This study focused on a new device that helps the heart by using direct compression instead of relying on blood contact, which can cause complications with current devices. Researchers tested their simulation tool, called Harvi, on data from 28 heart performance samples taken from four sheep, finding that it closely matched actual results from the animals. This accuracy means Harvi can help identify which patients might benefit most from this new device in future clinical trials. Who this helps: This helps patients with heart failure who may need advanced treatment options.

Plain English
Researchers looked at a new type of heart support device called direct cardiac compression (DCC), which doesn’t come into contact with blood like other devices currently used. The study highlighted how DCC devices can improve heart performance while reducing risks associated with blood contact, such as blood clots and the need for blood thinners. One DCC device is already being tested in people, with another one expected soon, making this technology particularly promising for improving heart treatment options. Who this helps: This helps patients with heart problems and the doctors treating them.

Plain English
The study examined a new heart device called the CorInnova, designed to help patients with heart failure by directly supporting the heart and improving its performance. In tests on animals, the device improved heart function significantly, showing promising results that suggest it could help patients who have few options for treatment, especially those with specific needs like right heart failure or allergies to blood thinners. This matters because it offers a new, less risky way to support heart function without the complications often associated with other devices. Who this helps: Patients with heart failure, especially those unable to use traditional treatment options.

Plain English
Researchers tested a new device designed to help hearts pump better in sheep with heart failure. They found that the device improved heart function significantly, showing better pumping pressure and blood flow measurements, without causing any damage to the heart after use. This is important because it could lead to new treatments for heart failure patients who struggle with their heart's ability to pump blood effectively. Who this helps: This helps patients with heart failure.

Plain English
This study looked at two types of heart surgery: one that avoids using a heart-lung machine (off-pump) and another that uses a heart-lung machine with minimal manipulation of the aorta (pump-assisted/no-clamp). They found that patients who had pump-assisted surgery did not experience strokes, while a small percentage (0.3%) of those who had off-pump surgery and 0.8% of those who had a combination of both did. The study shows that using pump-assisted techniques can help reduce the risk of stroke during surgery, but overall death rates were similar across all methods. Who this helps: This helps patients undergoing coronary artery bypass graft surgery and their doctors in choosing safer surgical options.

Plain English
This study looked at how patients who were on dialysis before receiving a heart device called a continuous-flow left ventricular assist device (CF-LVAD) fared after the procedure. Out of 621 patients, 31 had been on dialysis, with 17 on long-term dialysis and 14 on short-term dialysis. The findings showed that those on long-term dialysis had significantly better chances of survival six months (64.7% vs. 14.3%) and one year (58.8% vs. 7.1%) after the surgery compared to those on short-term dialysis, indicating that stable long-term dialysis patients can do well after the heart device is implanted. Who this helps: This benefits patients with chronic kidney disease who are stable on long-term dialysis and need heart support.

Plain English
Researchers documented a 25-year-old man who wore an artificial heart pump for over 5 years—longer than any previously reported case—and then successfully had it removed when his own heart recovered enough to work on its own. Artificial heart pumps save lives in people with severe heart failure, but they carry serious risks like stroke and infection, so doctors ideally want to remove them once the heart heals. This case shows that even after many years of pump support, a patient's heart can still recover enough to function without it, and doctors should keep trying to wean patients off these devices rather than assuming they'll need them forever.

Plain English
This study looked at the long-term outcomes of a heart surgery called heterotopic cardiac transplantation, where a new heart is added while the patient's original heart remains in place. Out of 39 patients studied, the survival rates were 69% after one year, 36% after five years, and 21% after ten years, with one patient living for 25 years post-surgery. The surgery is especially beneficial for obese patients and those with high pulmonary vascular resistance, as their original heart function often stabilizes over time. Who this helps: This helps patients with severe heart issues, particularly those who are obese or have high blood pressure in their lungs.

Plain English
This study looked at the long-term survival of a 46-year-old man who used a HeartMate II device to help his heart pump blood after multiple heart surgeries. After 10 years, he is still alive and has been able to work without issues while taking medication to prevent blood clots. The success might be due to good placement of the device and effective surgical techniques, indicating that careful procedures may lead to better outcomes for patients with similar heart conditions. Who this helps: This helps patients with advanced heart problems and their doctors by showing the potential long-term success of heart assist devices.

Plain English
The study looked at infections related to a specific heart pump, the Jarvik 2000, when the device’s power line exited the body from the lower rib area, known as a subcostal site. Out of 81 patients over nearly 14 years, there were only five minor infections linked to the pump, resulting in a very low infection rate of 0.002 infections per patient-year. This is important because it shows that using a subcostal exit site can effectively minimize infection risks, similar to previous findings with another exit site. Who this helps: This information benefits patients receiving heart pumps and the doctors who treat them.

Plain English
Doctors studied 27 patients who had mechanical heart pumps (devices that help failing hearts pump blood) successfully removed after their hearts recovered enough to work on their own. The researchers compared four different surgical techniques for removing these pumps, ranging from taking out the entire device to just disconnecting it while leaving parts behind. All four surgical approaches produced similar results—patients survived equally well regardless of which removal method was used, and complication rates like strokes and the need for follow-up surgery were the same across all groups. This matters because it shows doctors have flexibility in how they remove these devices without affecting patient outcomes, so they can choose the approach that makes sense for each individual patient's situation.

Plain English
This study looked at a young man with heart disease who received a device called HeartMate II to help his heart pump better. After a year, he developed a thyroid problem caused by a medication but, after treatment, both his thyroid and heart function improved significantly. Two years later, he had the device removed and six years after that, he still feels great with no heart issues. Who this helps: This benefits patients with heart failure and doctors treating them.

Plain English
This study looked at two types of heart surgeries—off-pump coronary artery bypass (OPCAB) and beating-heart coronary artery bypass (BH-CAB)—to see how they affected heart function in patients with weakened heart muscles. After surgery, both groups of patients showed improvements in heart function, with an average increase of 6.8% for BH-CAB patients and 5.4% for OPCAB patients. These findings are important because they indicate that both surgical approaches can lead to meaningful recovery in heart function, which could improve patients' overall health after surgery. Who this helps: This helps heart disease patients undergoing bypass surgery.

Plain English
This study compared two methods for fixing a leaky mitral valve: a newer, less invasive procedure using a clip and traditional surgery. While the clip method helped 55% of patients avoid serious issues after a year compared to 73% for surgery, it resulted in fewer complications right after the procedure—15% versus 48%. Overall, both methods improved heart function and quality of life for patients, but the clip offered a safer option. Who this helps: This helps patients with severe mitral regurgitation looking for safer treatment options.

Plain English
This research studied gastrointestinal (GI) bleeding in patients using the HeartMate II left ventricular assist device (LVAD) and looked for connections to arteriovenous malformations (AVMs). Out of 172 patients, 32 (19%) experienced GI bleeding after an average of about 63 days on the device, with 10 of those cases directly linked to AVMs. Importantly, all bleeding episodes were treated effectively without the need for surgery, which shows that while AVMs can cause complications, they can be managed safely in these patients. Who this helps: Patients with HeartMate II devices and their doctors.

Plain English
This study looked at a surgery called left ventricular reconstruction, which is used for patients with severe heart failure. The findings focus on a 43-year-old man who had this surgery and is still doing very well 10 years later, showing good heart function. This matters because it suggests that this surgical option could be a valid alternative for patients who cannot have a heart transplant. Who this helps: Patients with severe heart failure who are not candidates for a transplant.

Plain English
Researchers studied how a specific technique called selective left anterior descending (LAD) shunting during heart bypass surgeries (off-pump coronary artery bypass or OPCAB) can protect the heart. They looked at data from 408 patients and found that only four patients died from heart issues in those who didn't receive a shunt (1.4% mortality) compared to none in the shunted group. Additionally, the heart's pumping ability (ejection fraction) improved in both groups, suggesting shunting helps keep the heart stable during surgery. Who this helps: This benefits heart patients undergoing bypass surgery and the doctors treating them.

Plain English
This study looked at patients who underwent surgery after a procedure using the MitraClip device to fix issues with their heart's mitral valve. Out of 107 patients with serious mitral valve problems, 30% (32 patients) needed surgery later, with most (72%) having a clip placed during the initial procedure. The majority of these follow-up surgeries were successful even when performed up to 18 months later, ensuring that patients have options if the MitraClip treatment doesn't work as planned. Who this helps: This helps heart patients, particularly those with mitral regurgitation who might need additional surgery after initial treatment.

Plain English
This study compared two types of heart pumps in pigs to see which one works better during heart failure. The researchers found that a synchronized pulsatile pump provided better support for the heart than a continuous-flow pump, with measurements showing higher blood pressure and more effective blood circulation. Specifically, the pulsatile pump resulted in a total cardiac output of 5.58 compared to 5.12 for the continuous-flow pump. Who this helps: This benefits patients with severe heart failure who may require mechanical heart support.

Plain English
This study looked at how certain receptors in the heart change when patients receive a mechanical device to help their heart function better. Researchers took heart tissue samples from 19 patients before and after the device was removed. They found that after removing the device, all patients showed improvements in heart cell size, but not all types of receptors increased, with noticeable changes in the distribution of certain receptor types like beta(2) and alpha(1). Who this helps: This research benefits heart failure patients and their doctors by providing insights into heart recovery after using assist devices.

Plain English
This study looked at patients who have been using long-term left ventricular assist devices (LVAD) to help their hearts. Out of 33 patients, 17 were found to have some form of fusion in their aortic valve, which can lead to a condition called aortic insufficiency where the valve doesn't close properly. Specifically, 6 patients had significant issues with their aortic valve, and those with more severe fusion needed higher levels of LVAD support. Who this helps: This research benefits patients with long-term LVADs and their doctors by highlighting a common valve issue that may require additional care.

Plain English
This study looked at how mechanical support devices for the heart, like the HeartMate and Jarvik 2000, affect blood flow in patients with severe heart failure. Researchers found that when they increased the support provided by these devices, only one out of six patients showed a significant increase in blood flow, indicating that the devices may not effectively improve blood supply to the heart muscle. This is important because it suggests that simply providing more mechanical support might not solve the underlying problems with blood flow in heart failure patients. Who this helps: This helps patients with advanced heart failure and their doctors.

Plain English
Researchers studied a patient with severe heart failure who also had heart valve and artery issues. They performed a combination of surgeries—remodeling the left ventricle, repairing the mitral valve, and bypassing blocked coronary arteries. After the surgeries, the patient's heart function improved, indicating that this approach can be effective and safe together. Who this helps: This helps patients with severe heart failure who need multiple heart procedures.

Plain English
The study looked at three patients who had severe bleeding in their gastrointestinal tract after receiving a Jarvik 2000 heart pump. The bleeding was hard to control and only stopped for two of the patients after they received a heart transplant. This is important because it shows that this type of heart device can lead to serious complications that may require major surgery to fix. Who this helps: This helps patients with heart conditions who may need devices like the Jarvik 2000 and their doctors in managing potential complications.

Plain English
This study looked at how well the hearts of two patients with severe heart failure improved while using the Jarvik 2000 left ventricular assist device (LVAD). One patient showed a significant improvement in heart function, with a 75% increase in pumping ability, while the other patient’s function did not change much at all. The findings highlight that a specific measurement (the E(max)) was better at predicting heart improvement than a traditional method (the LVEF), which can help doctors understand when it might be safe to remove the device. Who this helps: This helps patients with end-stage heart failure and their doctors by giving insight into heart recovery while using assistive devices.

Plain English
The study looked at the current state of cardiac surgery and how it can improve in the future. It found that new surgical techniques and technologies can help many patients, including those with few options before. The recommendations made by experts include focusing on heart surgery methods, new treatments, and overcoming challenges in research to enhance patient care. Who this helps: This benefits patients needing heart surgery and health care providers aiming for better treatment outcomes.

Plain English
Researchers studied how continuous flow heart pumps, which are used to help patients with severe heart failure, can lead to blood clots in certain blood vessels. They found that in models of a narrowed artery, areas with low blood flow could form, increasing the risk of clots. This is important because patients with these pumps and existing blood vessel narrowing may face a higher risk of serious complications. Who this helps: This helps patients with severe heart failure who use continuous flow devices and have vascular issues.

Plain English
This study examined a new method called intravenous myocardial contrast echocardiography (MCE) to better identify areas of the heart that are alive but not functioning well, known as hibernating myocardium, in people with heart disease. The researchers tested 20 patients before heart surgery and found that 38% of the damaged areas showed recovery after surgery. The most accurate measurement from MCE for predicting recovery was a specific blood flow index, which had a sensitivity of 90%, comparable to a traditional imaging method, while being more specific. Who this helps: This helps patients with heart disease by improving the assessment of heart function before surgery.

Plain English
This study looked at how to better diagnose and manage bacterial endocarditis, an infection of the heart. It found that using the modified Duke criteria and specialized heart imaging called transesophageal echocardiography can help detect this disease earlier, especially for smaller growths on the heart (less than 10 mm), which are harder to see using standard imaging. It is important because patients with larger growths are at higher risk of serious complications, and combining medication with surgery leads to the best chance of survival for patients in critical condition. Who this helps: Patients with bacterial endocarditis and their doctors.

Plain English
This study looked at whether dogs could be successfully revived after being in a state of suspended circulation (where blood is not flowing) in very cold temperatures (between 2 to 4 degrees Celsius) for two hours. The researchers cooled nine dogs and replaced their blood with a special fluid, then stopped their circulation. They found that six out of the nine dogs fully recovered and had normal blood tests three weeks later, while one dog sadly died from an infection weeks after recovery, and three dogs didn't recover due to complications. Who this helps: This research benefits veterinary medicine and may improve rescue techniques for critically injured animals.

Plain English
This study looked at how well the Jarvik 2000 heart device, which helps pump blood, keeps the kidneys and liver functioning in patients waiting for a heart transplant. Ten patients used the device for more than six months, and all had normal liver function by the time they received their transplants, even if their kidney function had been impaired before. This is important because it shows that the device can effectively support vital organs while patients await life-saving surgery. Who this helps: Patients with severe heart problems who need a transplant.

Plain English
This study looked at a 63-year-old man with severe heart failure who had a heart surgery called dynamic cardiomyoplasty, which was successful. Thirty months later, he received a heart transplant, marking a rare case of someone getting a transplant after this type of surgery. This matters because it shows that heart transplants can still be an option for patients who have had prior heart procedures. Who this helps: Patients with severe heart failure who may need advanced cardiac interventions.

Plain English
This study looked at damaged heart muscle in patients with coronary artery disease who were undergoing bypass surgery. Researchers found that out of 28 heart segments examined, 23 had problems with heart function, and most of these segments were still viable. They discovered that segments that later improved in function had significantly more newly recruited inflammatory cells, indicating that an active inflammatory response can help the heart recover after surgery. Who this helps: This research benefits patients with coronary artery disease and their doctors by providing insights into how inflammation may influence heart recovery post-surgery.

Plain English
Researchers studied different techniques for repairing the front part of the mitral valve in the heart. They found that methods like shortening, moving, or replacing certain structures (called chords) of the valve can be safe and effective, improving patient outcomes. Using these repair techniques can lead to better heart function compared to replacing the valve entirely, which is important for patients with weak hearts. Who this helps: This helps patients with mitral valve issues, particularly those experiencing heart failure.

Plain English
This study examined heart tissue from 15 patients with coronary disease to see how the heart's structure changes during a condition called "myocardial hibernation," where parts of the heart become less active but may still recover. The researchers found that 24 out of 29 heart samples showed signs of dysfunction, but after surgery to improve blood flow, 12 of those samples regained function, especially those with specific markers indicating active remodeling in the heart tissue. This research highlights how the heart's ability to remodel itself can predict recovery after treatment, which is crucial for improving patient outcomes. Who this helps: This helps patients with heart disease who are undergoing procedures like bypass surgery.

Plain English
This study looked at how effective a method called diaphragmatic pacing is for people with severe paralysis in helping them breathe over many years. Out of 12 patients who received this treatment, 6 were able to use the pacing continuously for an average of nearly 15 years, while others stopped mainly due to lack of support or health issues. The findings show that this pacing method can be a long-term solution for patients, as it keeps their breathing stable without causing nerve damage. Who this helps: This helps patients with high cervical quadriplegia who need assistance with breathing.

Plain English
This study examined how the tiny blood vessels in the heart affect the ability to assess heart muscle health using a technique called myocardial contrast echocardiography (MCE) in patients with coronary artery disease and heart dysfunction. Researchers found that higher levels of heart muscle blood flow were linked to better microvascular density and larger capillary areas, while increased collagen content was associated with reduced blood flow. Specifically, they discovered a strong correlation between blood flow measurements and microvascular health, suggesting that these measures are crucial for predicting heart function recovery after treatment, with correlations as high as 0.87 (on a scale from 0 to 1). Who this helps: This helps patients with heart conditions, particularly those undergoing treatment for coronary artery disease.

Plain English
This study looked at different types of rings used in a heart surgery called mitral annuloplasty, which repairs the mitral valve. Researchers found that flexible rings are better than rigid ones because they improve heart function more effectively. Moving from rigid to flexible rings has been shown to further help patients, making the surgery safer and more successful overall. Who this helps: This helps patients with damaged mitral valves.

Plain English
This study examined patients with heart failure caused by damaged heart muscles to see how a measurement called deceleration time (DT) related to their heart health and recovery after surgery. Researchers found that a DT longer than 150 milliseconds indicated a better chance of heart function improving, with 79% accuracy for predicting significant recovery. Specifically, patients with a longer DT showed a notable increase in heart efficiency after surgery and had better survival rates than those with a shorter DT, highlighting the importance of assessing DT in treatment plans. Who this helps: Patients with ischemic cardiomyopathy and their doctors.

Plain English
The study examined how two techniques—cerebrospinal fluid drainage and distal aortic perfusion—affect neurological outcomes in patients undergoing surgery for descending thoracic aortic aneurysms. Researchers looked at 148 non-emergency patients and found that only 0.9% of those who received both techniques experienced neurological deficits, compared to 7% of those who did not use these methods. This means that using both techniques greatly reduces the risk of serious neurological problems after surgery, improving patient recovery. Who this helps: This benefits patients undergoing surgery for descending thoracic aortic aneurysms.

Plain English
This study looked at how well dog muscle can pump blood when used in heart assist devices, focusing on how pressure changes with different stimulation rates and muscle loads. Researchers found that muscles worked best at a stimulation frequency of 30 Hz, generating maximum pressure more quickly, while higher stimulation rates of over 50 Hz did not provide additional benefits. This matters because understanding these muscle characteristics can improve the effectiveness of heart assist treatments. Who this helps: Patients with heart failure who may benefit from improved cardiac support devices.

Plain English
This study focused on the surgical treatment of bacterial endocarditis, a serious infection of the heart valves often linked to drug use. It found that surgeries, which can include fixing or replacing damaged valves, are complex but have better results thanks to new techniques. This is important because timely and effective surgery can improve patients' heart health and their quality of life. Who this helps: This helps patients with bacterial endocarditis, especially those affected by intravenous drug use.

Plain English
This study investigated how heart tissue's daily function relates to its structure and the density of specific receptors that help regulate heart activity. Researchers looked at 10 patients with coronary artery disease and found that healthy heart tissue had more beta-adrenergic receptors and less fibrosis compared to dysfunctional areas. Specifically, normal heart segments had a receptor density of 2,280 compared to 1,373 in dysfunctional areas and showed better heart function, with systolic velocity measurements of 9.5 cm/s versus 5.9 cm/s in unhealthy segments. Who this helps: This research benefits patients with heart disease and their doctors, informing treatment decisions based on heart tissue health.

Plain English
This study looked at the levels of adrenergic receptors in heart tissue from patients with weakened heart function, specifically during a state known as myocardial hibernation, where the heart conserves energy. They found that heart segments with poor movement had 2.4 times more alpha receptors and half as many beta receptors compared to normal areas. These changes may help explain why the heart's function seems depressed at rest but can still respond under stress. Who this helps: This research benefits doctors treating patients with heart dysfunction, particularly those with ischemic conditions.

Plain English
This study looked at a new method for placing a heart device called a left ventricular assist device (LVAD) in patients who had heart surgery and developed heart failure. Researchers compared two techniques: one around the junction of the right pulmonary vein and left atrium, and the other at the dome of the left atrium. They found that using the dome position allowed for better blood flow and easier removal of the device, with 75% of patients able to leave the hospital after treatment, highlighting the improved care and outcomes for these heart patients. Who this helps: This benefits heart surgery patients who experience severe heart failure afterward.

Plain English
Researchers studied a new way to deliver cyclosporine A, a medication used to prevent organ rejection, directly to the lungs using a special type of aerosol. They found that this method significantly concentrates the drug in the lungs, with levels remaining elevated for about 120 minutes, while other organs had much lower drug concentrations. This is important because it may lead to more effective prevention of organ rejection in patients receiving lung transplants with fewer side effects. Who this helps: This helps patients undergoing lung transplants.